The New York Times - May 10, 2022
Shelby Freedman Harris, Psy.D., says infants and preschoolers commonly move around during sleep and may end up in positions adults think are awkward, but are comfortable for children. Dr. Harris is clinical associate professor in The Saul R. Korey Department of Neurology and of psychiatry and behavioral sciences at Einstein. (subscription required)
Dr. Harris's ProfileMore coverage on Dr. Harris
Bronx Times - May 10, 2022
Mamta Fuloria, M.B.B.S., and Suzette Oyeku, M.D., M.P.H., discuss several ways to combat childhood obesity, including creating healthy eating and exercise habits and making healthy food accessible and affordable. Dr. Fuloria is associate professor of pediatrics at Einstein and a neonatologist at Montefiore. Dr. Oyeku is professor of pediatrics at Einstein and chief of the division of academic general pediatrics at Einstein and the Children's Hospital at Montefiore.
Dr. Fuloria's Profile
The Conversation - April 20, 2022
Steven Walkley, D.V.M., Ph.D., and Melissa Wasserstein, M.D., write about the science behind rare diseases and the research and clinical care that Einstein and Montefiore experts provide to families of children with uncommon genetic disorders. Dr. Walkley is co-director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in the Dominick P. Purpura Department of Neuroscience, of pathology, and in the Saul R. Korey Department of Neurology. Dr. Wasserstein is professor of pediatrics and of genetics at Einstein and chief of the division of pediatric genetic medicine at Einstein and Montefiore.
Dr. Walkley's ProfileMore coverage on Dr. Walkley
AAMC News - April 19, 2022
Fourth-year medical student Rachel Reingold, Joanne Siegel, M.S., and Felise Milan, M.D., discuss the creation and value of Einstein's medical school curriculum on intellectual and developmental disabilities. Ms. Siegel is principal associate of pediatrics and co-director of Einstein's Rose F. Kennedy University Center for Excellence in Developmental Disabilities. Dr. Milan is professor of medicine, director of the Clinical Skills Center, and director of the Introduction to Clinical Medicine Programs for first- and second-year medical students at Einstein.
Dr. Siegel's ProfileMore coverage on Dr. Siegel
The Conversation - April 14, 2022
Andrew Williams, M.D., writes about Medicare's coverage restrictions on the new Alzheimer's disease drug Aduhelm and explores the drug's mixed results in clinical trials. Dr. Williams is assistant professor of emergency medicine at Einstein and an emergency medicine physician at Montefiore.
Dr. Williams's Profile
AAMC News - April 14, 2022
Susan Klugman, M.D., comments on prenatal screenings, noting the differences between screenings, which detect potential disease, and tests that provide a diagnosis. Dr. Klugman is professor of pediatrics and of obstetrics & gynecology and women's health at Einstein, and director of reproductive and medical genetics at Montefiore.
Dr. Klugman's ProfileMore coverage on Dr. Klugman
US News & World Report - April 13, 2022
Simon Spivack, M.D., M.P.H., and Jan Vijg, Ph.D., explain their study that suggests some smokers don't develop lung cancer because they have strong natural protection against cancer-causing mutations in lung cells. Dr. Spivack is professor of medicine, of epidemiology & population health, and of genetics at Einstein, and a pulmonologist at Montefiore Health System. Dr. Vijg is professor and chair of genetics, professor of ophthalmology and visual sciences, and the Lola and Saul Kramer Chair in Molecular Genetics at Einstein.
Additional coverage includes UPI, Medical News Today, Genome Web
Dr. Spivak's Profile
BronxNet - April 13, 2022
Edward Chu, M.D., M.M.S., discusses the expertise of recent leadership appointments at the Montefiore Einstein Cancer Center (MECC), along with the center’s research, clinical care, and Bronx community engagement. Dr. Chu is director of MECC, vice president for cancer medicine at Montefiore Medicine, interim chairman of the department of oncology, and the Carol and Roger Einiger Professer of Cancer Medicine at Einstein.
Dr. Chu's ProfileMore coverage on Dr. Chu
Discover Magazine - April 7, 2022
Jonathan Alpert, M.D., Ph.D., discusses a new neurostimulation therapy that uses magnetic pulses to treat depression, and notes that it is among the emerging options that appear to work quickly to heal some patients' brains. Dr. Alpert is the Dorothy and Marty Silverman Chair in Psychiatry at Einstein and is chair and professor of psychiatry and behavioral sciences at Einstein and Montefiore.
Dr. Alpert's ProfileMore coverage on Dr. Alpert
BronxNet - April 6, 2022
Fourth-year Albert Einstein College of Medicine medical students April Sosa, Emily Bruder, and Daniel Baghdasarian discuss their recent residency matches to Montefiore Health System.
The Scientist - March 25, 2022
Maja Oktay, M.D., Ph.D., talks about cancer metastasis and the tumor microenvironment, which she and colleagues have extensively studied, and how chemotherapy may promote the spread of cancer. Dr. Oktay is professor of pathology and director of the New York Pathology Oncology Group.
Dr. Oktay's ProfileMore coverage on Dr. Oktay
News12 - March 18, 2022
Albert Einstein College of Medicine fourth-year medical students, who spent their clinical years on hospital wards during the COVID-19 pandemic, celebrated Match Day, learning where they will start the next phase of their medical education as resident physicians. Thirty will join an Einstein-affiliated residency program, including 28 at Montefiore.
Medical News Today - March 11, 2022
Michael Lipton, M.D., Ph.D., notes the limitations of a small study linking nerve damage in long COVID to immune dysfunction, but says the underlying mechanism causing neuropathy is likely related to inflammation or autoimmunity. Dr. Lipton is professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein, and director of MRI Services at Montefiore.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
Drug Discovery News - April 17, 2022
Nicholas Baker, Ph.D., discusses a study that discovered how epithelial cells interact with precancerous cells, recognizing them and removing them from the body. Dr. Baker is professor of genetics, of developmental and molecular biology, and of ophthalmology and visual sciences, and is the Harold and Muriel Block Chair in Genetics.
Dr. Baker's ProfileMore coverage on Dr. Baker
Healio - January 26, 2022
Tiffany Lu, M.D., M.S., describes her grant that will fund the expansion of addiction medicine and training programs for medical students and residents at Einstein and Montefiore. The curriculum will focus on the diagnosis and care for people with opioid use disorder, including guidance about medications for addiction treatment, particularly buprenorphine. Dr. Lu is assistant professor of medicine at Einstein and director of the Montefiore Buprenorphine Treatment Network.
Dr. Lu's Profile
Review of Ophthamology - October 10, 2021
Roy Chuck, M.D., Ph.D., describes the benefits of a new contact lens-like device, patented by Montefiore and Einstein, that is used in a treatment for keratoconus, an eye disease that affects the structure of the cornea. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
Nature - September 2, 2020
In a commentary for Nature, Gary Schwartz, Ph.D., writes about the discovery of a pathway in the preoptic area of the brain in mice by which a light-sensitive protein regulates heat production. The findings may lead to ways of altering metabolism by manipulating environmental light. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile